Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.

Saud Alhusaini,Tyler A Lanman,Ryan B Ko, Kate E Therkelsen,Rie Von Eyben,Maximilian Diehn,Scott G Soltys,Erqi L Pollom,Alexander Chin,Lucas Vitzthum,Heather A Wakelee,Sukhmani K Padda,Kavitha Ramchandran,Billy W Loo,Joel W Neal,Seema Nagpal

Frontiers in oncology（2023）

引用 0|浏览48

暂无评分

摘要

At our center, BrMs incidence in stage III NSCLC patients was lower than historically reported but notably higher than the incidence described in recent clinical trials. Routine BrMs surveillance potentially allows earlier detection of asymptomatic BrMs. However, asymptomatic BrMs were mostly detected on restaging MRI at the time of recurrence.

查看译文

关键词

MRI brain,brain metastases,incidence,non-small cell lung cancer,surveillance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要